- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1386241 [Title] => Pag-inom ng gatas, nakakamatay? [Summary] =>Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.
[DatePublished] => 2014-10-31 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 1369717 [Title] => Why you should keep plants in the office [Summary] =>We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk.
[DatePublished] => 2014-09-16 11:26:13 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1121281 [AuthorName] => Alixandra Caole Vila [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg ) [2] => Array ( [ArticleID] => 322917 [Title] => Pinoy docs in most extensive anti-blood clot clinical trial [Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.
The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.
Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
UPPSALA UNIVERSITY
Array ( [results] => Array ( [0] => Array ( [ArticleID] => 1386241 [Title] => Pag-inom ng gatas, nakakamatay? [Summary] =>Maraming nagsasabi na ang pag-inom ng gatas ay nakakapatibay ng buto.
[DatePublished] => 2014-10-31 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Para Malibang [SectionUrl] => para-malibang [URL] => ) [1] => Array ( [ArticleID] => 1369717 [Title] => Why you should keep plants in the office [Summary] =>We all know that adding few potted plants bring a comfortable feel to your work space. But apart from the visual appeal that plants provide, there are much more reasons why you should put a touch of green on your desk.
[DatePublished] => 2014-09-16 11:26:13 [ColumnID] => 0 [Focus] => 0 [AuthorID] => 1121281 [AuthorName] => Alixandra Caole Vila [SectionName] => Health And Family [SectionUrl] => health-and-family [URL] => http://media.philstar.com/images/the-philippine-star/lifestyle/health-and-family/20140916/potted-plants-office.jpg ) [2] => Array ( [ArticleID] => 322917 [Title] => Pinoy docs in most extensive anti-blood clot clinical trial [Summary] => Boehringer-Ingelheim has launched the biggest ever thromboembolic disease clinical trial program.
The trials under the umbrella name RE-VOLUTION and involving more than 27,000 patients worldwide, will investigate a novel oral direct thrombin inhibitor, dabigatran etexilate, researched and developed by the Germany-based pharmaceutical company to prevent and treat thromboembolic disease.
Dabigatran etexilate is a promising new oral direct thrombin inhibitor that specifically and reversibly inhibits thrombin, the key enzyme for blood clot formation.
[DatePublished] => 2006-02-23 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
EZ2/LVM - 25 11
SUERTRES - 7 2 1
6D Lotto - 8 6 4 1 1 5
6/42 Lotto - 22 24 10 34 2 35
P107,852,598.00
6/49 Super Lotto - 33 25 19 24 38 35
P104,130,972.00
6/58 Ultra Lotto - 42 58 37 51 2 38
P101,900,031.00
- 12:00 am